CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Endo USA, Inc. recalls Everolimus tablets 5mg

Read the official FDA notice

Published
22 Oct 2025
Units affected
1,041 cartons
Agency
FDA
Country
United States

The hazard

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91

Brand / company
Endo USA, Inc.
Codes / lots
Lot #: 550172301, Exp. Date January 2026
Distribution
Nationwide within the United States
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 22 Oct 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.